<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">Peritoneal carcinomatosis</z:e> caused by colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> is still considered as the end-stage of disease </plain></SENT>
<SENT sid="1" pm="."><plain>A multi-modal therapeutic concept including maximal cytoreduction followed by intraperitoneal hyperthermic chemotherapy (HIPEC) has the potential to cure selected patients </plain></SENT>
<SENT sid="2" pm="."><plain>In case of <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> palliative systemic treatment is no longer the state of the art </plain></SENT>
<SENT sid="3" pm="."><plain>This article addresses aspects of the disease, the rationale behind peritonectomy with HIPEC, and the surgical management of <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> </plain></SENT>
</text></document>